Persistent chlamydiae: From cell culture to a paradigm for chlamydial pathogenesis

Microbiological Reviews

Volumn 58, Issue 4, 1994, Pages 686-699

  Beatty, Wandy L ^a   Morrison, Richard P ^b   Byrne, Gerald I ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL INTERACTION; CELL MATURATION; CHLAMYDIA TRACHOMATIS; CHLAMYDIACEAE; EYE INFECTION; GENITAL TRACT INFECTION; METABOLIC CAPACITY; NONHUMAN; PATHOGENESIS; PERSISTENT INFECTION; REINFECTION; REVIEW;

CHLAMYDIA TRACHOMATIS; CHLAMYDIACEAE; CHLAMYDIAE;

EID: 0027946866     PISSN: 01460749     EISSN: None     Source Type: Journal    
DOI: 10.1128/mmbr.58.4.686-699.1994     Document Type: Review

References (129)

1. Allan, I., T. P. Hatch, and J. H. Pearce. 1985. Influence of cysteine deprivation on chlamydial differentiation from reproductive to infective life-cycle forms. J. Gen. Microbiol. 131:3171-3177.
2. Allan, I., and J. H. Pearce. 1983. Amino acid requirements of strains of Chlamydia trachomatis and C. psittaci in McCoy cells: relationship with clinical syndrome and host origin. J. Gen. Microbiol. 129:2001-2007.
3. Armstrong, J. A., and S. E. Reed. 1967. Fine structure of lymphogranuloma venereum agent and the effects of penicillin and 5-fluorouracil. J. Gen. Microbiol. 46:435-444.
4. Bader, J. P., and H. R. Morgan. 1958. Latent viral infection of cells in tissue culture. VI. Role of amino acids, glutamine and glucose in psittacosis virus propagation in L cells. J. Exp. Med. 106:617-629.
5. Bader, J. P., and H. R. Morgan. 1961. Latent viral infection of cells in tissue culture. VII. Role of water soluble vitamins in psittacosis virus propagation in L cells. J. Exp. Med. 113:271-281.
6. Barbour, A. G., K.-I. Amato, T. Hackstadt, L. Perry, and H. D. Caldwell. 1982. Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J. Bacteriol. 151:420-428.
7. Barry, C. E., III, S. F. Hayes, and T. Hackstadt. 1992. Nucleoid condensation in Escherichia coli that express a chlamydial histone homolog. Science 256:377-379.
8. Batteiger, B. E., J. Fraiz, W. J. Newhall, V., B. P. Katz, and R. B. Jones. 1989. Association of recurrent chlamydial infection with gonorrhea. J. Infect. Dis. 159:661-669.
9. Bavoil, P., A. Ohlin, and J. Schachter. 1984. Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis. Infect. Immun. 44:479-485.
10. Beatty, W. L., G. I. Byrne, and R. P. Morrison. 1993. Morphological and antigenic characterization of interferon-γ mediated persistent Chlamydia trachomatis infection in vitro. Proc. Natl. Acad. Sci. USA 90:3998-4002.
11. Beatty, W. L., R. P. Morrison, and G. I. Byrne. 1993. Characterization of long term chlamydial persistence and recovery of infectivity in cell culture, abstr. D-151. Program Abstr. 93rd Gen. Meet. Am. Soc. Microbiol. 1993. American Society for Microbiology, Washington, D.C.
12. Brownridge, E., and P. B. Wyrick. 1979. Interaction of Chlamydia psittaci reticulate bodies with mouse peritoneal macrophages. Infect. Immun. 24:697-700.
13. Brunham, R. C., I. W. Maclean, B. Binns, and R. W. Peeling. 1985. Chlamydia trachomatis: its role in tubal infertility. J. Infect. Dis. 152:1275-1282.
14. Byrne, G. I., and C. L. Faubion. 1982. Lymphokine-mediated microbistatic mechanisms restrict Chlamydia psittaci growth in macrophages. J. Immunol. 128:469-474.
15. Byrne, G. I., and C. L. Faubion. 1983. Inhibition of Chlamydia psittaci in oxidatively active thioglycolate-elicited macrophages: distinction between lymphokine-mediated oxygen-dependent and oxygen-independent macrophage activation. Infect. Immun. 40:464-471.
16. Byrne, G. I., and D. A. Krueger. 1983. Lymphokine-mediated inhibition of Chlamydia psittaci replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin. Infect. Immun. 42:1152-1158.
17. Byrne, G. I., L. K. Lehmann. and G. J. Landry. 1986. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect. Immun. 53:347-351.
18. Campbell, L. A., D. L. Patton, D. E. Moore, A. L. Cappuccio, B. A. Mueller, and S.-P. Wang. 1993. Detection of Chlamydia trachomatis deoxyribonucleic acid in women with tubal infertility. Fertil. Steril. 59:45-50.
19. Campbell, S., S. J. Richmond, P. Haynes, D. Gump, P. Yates, and T. D. Allen. 1988. An in vitro model of Chlamydia trachomatis infection in the generation phase of the human endometrial cycle. J. Gen. Microbiol. 134:2077-2087.
20. Cates, W., Jr., and J. H. Wasserheit. 1991. Genital chlamydial infections: epidemiology and reproductive sequelae. Am. J. Obstet. Gynecol. 164:1771-1781.
21. Cevenini, R., M. Donati, and M. La Placa. 1988. Effects of penicillin on the synthesis of membrane proteins of Chlamydia trachomatis LGV2 serotype. FEMS Microbiol. Lett. 56:41-46.
22. Cheema, M. A., H. R. Schumacher, and A. P. Hudson. 1991. RNA-directed molecular hybridization screening: evidence for inapparent chlamydial infection. Am. J. Med. Sci. 302:261-268.
23. Clark, R. B., P. F. Schatzki, and H. P. Dalton. 1982. Ultrastructural analysis of the effects of erythromycin on the morphology and developmental cycle of Chlamydia trachomatis HAR-13. Arch. Microbiol. 133:278-282.
24. Clark, R. B., P. F. Schatzki, and H. P. Dalton. 1982. Ultrastructural effect of penicillin and cyclohexamide on Chlamydia trachomatis strain HAR-13. Med. Microbiol. Immunol. (Berlin) 171:151-159.
25. Coles, A. M., D. J. Reynolds, A. Harper, A. Devitt, and J. H. Pearce. 1993. Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis? FEMS Microbiol. Lett. 106:193-200.
26. de la Maza, L. M., E. M. Peterson, C. W. Fennie, and C. W. Czarniecki. 1985. The anti-chlamydial and anti-proliferative activities of recombinant murine interferon-γ are not dependent on tryptophan concentrations. J. Immunol. 135:4198-4200.
27. Ellis, R. J. 1991. Molecular chaperones. Annu. Rev. Biochem. 60:321-347.
28. Everett, K. D. E., and T. P. Hatch. 1991. Sequence analysis and lipid modification of the cysteine-rich envelope proteins of Chlamydia psittaci 6BC. J. Bacteriol. 173:3821-3830.
29. Everett, K. D. E., and T. P. Hatch. 1993. Cell wall architecture of Chlamydia, abstr. D-148. Program Abstr. 93rd Gen. Meet. Am. Soc. Microbiol. 1993. American Society for Microbiology, Washington, D.C.
30. Galasso, G. J., and G. P. Manire. 1961. Effect of antiserum and antibiotics on persistent infection of HeLa cells with meningopneumonitis virus. J. Immunol. 86:382-385.
31. Garrett, A. J., M. J. Harrison, and G. P. Manire. 1974. A search for the bacterial mucopeptide component muramic acid in Chlamydia. J. Gen. Microbiol. 80:315-318.
32. Grayston, J. T., and S.-P. Wang. 1975. New knowledge of chlamydiae and the diseases they cause. J. Infect. Dis. 132:87-104.
33. Hackstadt, T., W. Baehr, and Y. Yuan. 1991. Chlamydia trachomatis developmentally regulated protein is homologous to eukaryotic histone H1. Proc. Natl. Acad. Sci. USA 88:3937-3941.
34. Hackstadt, T., W. J. Todd, and H. D. Caldwell. 1985. Disulfide-mediated interactions of the chlamydial major outer membrane protein: role in the differentiation of chlamydiae? J. Bacteriol. 161:25-31.
35. Hammerschlag, M. R. 1982. Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro. Rev. Infect. Dis. 4:500-505.
36. Hammerschlag, M. R., and J. C. Vuletin. 1985. Ultrastructural analysis of the effect of trimethoprim and sulphamethoxazole on the development of Chlamydia trachomatis in cell culture. J. Antimicrob. Chemother. 15:209-217.
37. Hanna, L., C. R. Dawson, O. Briones, P. Thygeson, and E. Jawetz. 1968. Latency in human infections with TRIC agents. J. Immunol. 101:43-50.
38. Hanna, L., T. C. Merigan, and E. Jawetz. 1966. Inhibition of TRIC agents by virus induced interferon. Proc. Soc. Exp. Biol. Med. 122:417-421.
39. Hatch, T. P. 1975. Competition between Chlamydia psittaci and L cells for host isoleucine pools: a limiting factor in chlamydial multiplication. Infect. Immun. 12:211-220.
40. Hatch, T. P. 1988. Metabolism of Chlamydia, p. 97-110. In A. L. Baron (ed.), Microbiology of chlamydiae. CRC Press, Inc., Boca Raton, Fia.
41. Hatch, T. P., E. Al-Hossainy, and J. A. Silverman. 1982. Adenine nucleotide and lysine transport in Chlamydia psittaci. J. Bacteriol. 150:662-670.
42. Hatch, T. P., I. Allan, and J. H. Pearce. 1984. Structural and polypeptide differences between envelopes of infective and reproductive life cycle forms of Chlamydia spp. J. Bacteriol. 157:13-20.
43. Hatch, T. P., M. Miceli, and J. E. Sublett. 1986. Synthesis of disulfide-bonded outer membrane proteins during the developmental cycle of Chlamydia psittaci and Chlamydia trachomatis. J. Bacteriol. 165:379-385.
44. Henry-Suchet, J., F. Catalan, V. Loffredo, M. J. Sanson, C. Debache, F. Pigeau, and R. Coppin. 1981. Chlamydia trachomatis associated with chronic inflammation in abdominal specimens from women selected for tuboplasty. Fertil. Steril. 36:599-605.
45. Henry-Suchet, J., C. Utzmann, J. E. J. De Brux, P. Ardoin, and F. Catalan. 1987. Microbiological study of chronic inflammation associated with tubal factor infertility: role of Chlamydia trachomatis. Fertil. Steril. 47:274-277.
46. Holland, S. M., A. P. Hudson, L. Bobo, J. A. Whittum-Hudson, R. P. Viscidi, T. C. Quinn, and H. R. Taylor. 1992. Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect. Immun. 60:2040-2047.
47. Hooton, T. M., M. E. Rogers, T. G. Medina, L. E. Kuwamura, C. Ewers, P. L. Roberts, and W. E. Stamm. 1990. Ciprofloxacin compared with doxycycline for nongonococcal urethritis. Ineffectiveness against Chlamydia trachomatis due to relapsing infection. JAMA 264:1418-1421.
48. Hudson, A. P., C. M. McEntee, M. Reacher, J. A. Whittum-Hudson, and H. R. Taylor. 1992. Inapparent ocular infection by Chlamydia trachomatis in experimental and human trachoma. Curr. Eye Res. 11:279-283.
49. Johnson, F. W. A., and D. Hobson. 1977. The effect of penicillin on genital strains of Chlamydia trachomatis in tissue culture. J. Antimicrob. Chemother. 3:49-56.
50. Jones, H., G. Rake, and B. Stearns. 1945. Studies of lymphogranuloma venereum. III. The action of the sulfonomides on the agent of lymphogranuloma venereum. J. Infect. Dis. 76:55-09.
51. Jones, R. B., B. R. Ardery, S. L. Hui, and R. E. Cleary. 1982. Correlation between serum antichlamydial antibodies and tubal factors as a cause of infertility. Fertil. Steril. 38:553-558.
52. Jones, R. B., B. van der Pol, D. H. Martin, and M. K. Shepard. 1990. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J. Infect. Dis. 162:1309-1315.
53. Kahane, S., and M. G. Friedman. 1992. Reversibility of heat shock in Chlamydia trachomatis. FEMS Microbiol. Lett. 97:25-30.
54. Kane, J. L., R. M. Woodland, T. Forsey, S. Darougar, and M. G. Elder. 1984. Evidence of chlamydial infection in infertile women with and without fallopian tube obstruction. Fertil. Steril. 42:843-848.
55. Kaul, R., S. Tao, and W. M. Wenman. 1990. Cyclic AMP inhibits protein synthesis in Chlamydia trachomatis at a transcriptional level. Biochim. Biophys. Acta 1053:106-112.
56. Kaul, R., and W. M. Wenman. 1986. Cyclic AMP inhibits developmental regulation of Chlamydia trachomatis. J. Bacteriol. 168:722-727.
57. Kazar, J., J. D. Gillmore, and F. B. Gordon. 1971. Effect of interferon and interferon inducers on infection with a nonviral intracellular microorganism, Chlamydia trachomatis. Infect. Immun. 3:825-832.
58. Kiviat, N. B., P. Wolner-Hanssen, M. Peterson, J. Wasserheit, W. E. Stamm, D. A. Eschenbach, J. Paavonen, J. Lingenfelter, T. Bell, V. Zabriskie, B. Kirby, and K. K. Holmes. 1986. Localization of Chlamydia trachomatis infection by direct immunofluorescence and culture in pelvic inflammatory disease. Am. J. Obstet. Gynecol. 154:865-873.
59. Kramer, M. J., and F. B. Gordon. 1971. Ultrastructural analysis of the effects of penicillin and chlortetracycline on the development of a genital tract Chlamydia. Infect. Immun. 3:333-341.
60. Lin, H.-S., and J. W. Moulder. 1966. Patterns of response to sulfadiazine, D-cycloserine, and D-alanine in members of the psittacosis group. J. Infect. Dis. 116:372-376.
61. Lundemose, A. G., S. Birkelund, P. M. Larsen, S. J. Fey, and G. Christiansen. 1990. Characterization and identification of early proteins in Chlamydia trachomatis serovar L2 by two-dimensional gel electrophoresis. Infect. Immun. 58:2478-2486.
62. Lundemose, A. G., J. E. Kay, and J. H. Pearce. 1993. Chlamydia trachomatis Mip-like protein has peptidyl-prolyl cis/trans isomerase activity that is inhibited by FK506 and rapamycin and is implicated in initiation of chlamydial infection. Mol. Microbiol. 7:777-783.
63. Lundemose, A. G., D. A. Rouch, S. Birkelund, G. Christiansen, and J. H. Pearce. 1992. Chlamydia trachomatis Mip-like protein. Mol. Microbiol. 6:2539-2548.
64. Mabey, D. C. W., J. N. Robertson, and M. E. Ward. 1987. Detection of Chlamydia trachomatis by enzyme immunoassay in patients with trachoma. Lancet ii:1491-1492.
65. MacDonald, A. B., K. A. Tham, and E. S. Stuart. 1986. Persistent infection of BHK cells with Chlamydia trachomatis can be switched to an overt infection by treatment with cyclic nucleotides, p. 67-70. In J. D. Oriel, G. Ridgway, J. Schachter, D. Taylor-Robinson, and M. Ward (ed.), Chlamydial infections. Cambridge University Press, Cambridge.
66. Manor, E., and I. Sarov. 1988. Inhibition of Chlamydia trachomatis replication in HEp-2 cells by human monocyte-derived macrophages. Infect. Immun. 56:3280-3284.
67. Matsumoto, A., and G. P. Manire. 1970. Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J. Bacteriol. 101:278-285.
68. Merigan, T. C., and L. Hanna. 1966. Characteristics of interferon induced in vitro and in vivo by a TRIC agent. Proc. Soc. Exp. Biol. Med. 122:421-424.
69. Meyer, K. F., and B. Eddie. 1933. Latent psittacosis infection in shell parakeets. Proc. Soc. Exp. Biol. Med. 30:483-488.
70. Moore, D. E., L. R. Spadoni, H. M. Foy, S.-P. Wang, J. R. Daling, C.-C. Kuo, J. T. Grayston, and D. A. Eschenbach. 1982. Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet ii:574-577.
71. Morgan, H. R. 1956. Latent viral infection of cells in tissue culture. I. Studies on latent infection of chick embryo tissues with psittacosis virus. J. Exp. Med. 103:37-47.
72. Morrison, R. P., R. J. Belland, K. Lyng, and H. D. Caldwell. 1989. Chlamydial disease pathogenesis: the 57-kD chlamydial hypersensitivity antigen is a stress response protein. J. Exp. Med. 170:1271-1283.
73. Morrison, R. P., K. Lyng, and H. D. Caldwell. 1989. Chlamydial disease pathogenesis: ocular hypersensitivity elicited by a genus-specific 57-kD protein. J. Exp. Med. 169:663-675.
74. Moulder, J. W. 1962. The psittacosis-lymphogranuloma venereum group, p. 122-124. in P. P. H. DeBruyn (ed.), The biochemistry of intracellular parasitism. The University of Chicago Press, Chicago.
75. Moulder, J. W. 1964. The psittacosis group as bacteria. CIBA lectures in microbial biochemistry. John Wiley & Sons, Inc., New York.
76. Moulder, J. W. 1993. Why is Chlamydia sensitive to penicillin in the absence of peptidoglycan? Infect. Agents Dis. 2:87-99.
77. Moulder, J. W., N. J. Levy, and R. P. Schulman. 1980. Persistent infection of mouse fibroblasts (L cells) with Chlamydia psittaci: evidence for a cryptic chlamydial form. Infect. Immun. 30:874-883.
78. Moulder, J. W., D. L. Novosel, and J. E. Officer. 1963. Inhibition of the growth of agents of the psittacosis group by D-cycloserine and its specific reversal by D-alanine. J. Bacteriol. 85:707-711.
79. Newhall, W. J., V. 1987. Biosynthesis and disulfide cross-linking of outer membrane components during the growth cycle of Chlamydia trachomatis. Infect. Immun. 55:162-168.
80. Officer, J. E., and A. Brown. 1961. Serial changes in virus and cells in culture chronically infected with psittacosis virus. Virology 14:88-99.
81. Oriel, J. D. 1986. The carrier state: Chlamydia trachomatis. J. Antimicrob. Chemother. 18SA:67-71.
82. Oriel, J. D., and G. L. Ridgway. 1982. Genital infection by Chlamydia trachomatis, p. 86-98. Elsevier Science Publishing, Inc., New York.
83. Oriel, J. D., and G. L. Ridgway. 1982. Studies of the epidemiology of chlamydial infection of the human genital tract, p. 425. In P.-A. Mardh, K. K. Holmes, J. D. Oriel, P. Piot, and J. Schachter (ed.), Chlamydial infections. Elsevier Biomedical Press, Amsterdam.
84. Patton, D. L., D. E. Moore, L. R. Spadoni, M. R. Soules, S. A. Halbert, and S.-P. Wang. 1989. A comparison of the fallopian tube's response to overt and silent salpingitis. Obstet. Gynecol. 73:622-630.
85. Perara, E., D. Ganem, and J. N. Engel. 1992. A developmentally regulated chlamydial gene with apparent homology to eukaryotic histone H1. Proc. Natl. Acad. Sci. USA 89:2125-2129.
86. Perez-Martinez, J. A., and J. Storz. 1985. Persistent infection of L cells with an ovine abortion strain of Chlamydia psittaci. Infect. Immun. 50:453-458.
87. Pfefferkorn, E. R. 1984. Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cell degrade tryptophan. Proc. Natl. Acad. Sci. USA 81:908-912.
88. Phillips, D. M., C. E. Swenson, and J. Schachter. 1984. Ultrastructure of Chlamydia trachomatis infection of the mouse oviduct. J. Ultrastruct. Res. 88:244-256.
89. Plaunt, M. R., and T. P. Hatch. 1988. Protein synthesis early in the developmental cycle of Chlamydia psittaci. Infect. Immun. 56:3021-3025.
90. Pollard, M., and N. Sharon. 1963. Induction of prolonged latency in psittacosis infected cells by aminopterin. Proc. Soc. Exp. Biol Med. 112:51-55.
91. Rahman, M. U., M. A. Cheema, H. R. Schumacher, and A. P. Hudson. 1992. Molecular evidence for the presence of Chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum. 35:521-529.
92. Rapoza, P. A., S. G. Tahija, J. M. Carlin, S. L. Miller, M. L. Padilla, and G. I. Byrne. 1991. Effect of interferon on a primary conjunctival epithelial cell model of trachoma. Invest. Ophthalmol. Visual Sci. 32:2919-2923.
93. Reeve, P., and J. Taverne. 1968. Inhibition by pyrimidine analogues of the synthesis of folic acid by trachoma agents. J. Hyg. Camb. 66:295-306.
94. Rosenkranz, H. S., B. Gutter, and Y. Becker. 1973. Studies on the developmental cycle of Chlamydia trachomatis: selective inhibition by hydroxyurea. J. Bacteriol. 115:682-690.
95. Rothermel, C. D., G. I. Byrne, and E. A. Havell. 1983. Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells). Infect. Immun. 39:362-370.
96. Rothermel, C. D., B. Y. Rubin, E. A. Jaffe, and H. W. Murray. 1986. Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-γ-activated macrophages. J. Immunol. 137:689-692.
97. Rothermel, C. D., B. Y. Rubin, and H. W. Murray. 1983. γ-Interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication. J. Immunol. 131:2542-2544.
98. Sardinia, L. M., E. Segal, and D. Ganem. 1988. Developmental regulation of the cysteine-rich outer-membrane proteins of murine Chlamydia trachomatis. J. Gen. Microbiol. 134:997-1004.
99. Sarov, I., E. Geron, Y. Shemer-Avni, E. Manor, M. Zvillich, D. Wallach, E. Schmitz, and H. Holtman. 1991. Implications for persistent chlamydial infections of phagocyte-microorganism interplay. Eur. J. Clin. Microbiol. Infect. Dis. 10:119-123.
100. Schachter, J. 1967. A bedsonia isolated from a patient with clinical lymphogranuloma venereum. Am. J. Ophthalmol. 63:1049-1056.
101. Schachter, J. 1978. Chlamydial infections. N. Engl. J. Med. 298:428-435.
102. Schachter, J., J. Moncada, C. R. Dawson, J. Sheppard, P. Courtright, M. E. Said, S. Zaki, S. F. Hafez, and A. Loinez. 1988. Nonculture methods for diagnosing chlamydial infection in patients with trachoma: a clue to the pathogenesis of the disease? J. Infect. Dis. 158:1347-1352.
103. Sellors, J. W., J. B. Mahony, M. A. Chernesky, and D. J. Rath. 1988. Tubal factor infertility: an association with prior chlamydial infection and asymptomatic salpingitis. Fertil. Steril. 49:451-457.
104. Shainkin-Kestenbaum, R., Y. Winikoff, R. Kol, C. Chaimovitz, and I. Sarov. 1989. Inhibition of growth of Chlamydia trachomatis by the calcium antagonist Verapamil. J. Gen. Microbiol. 135:1619-1623.
105. Shemer, Y., R. Kol, and I. Sarov. 1987. Tryptophan reversal of recombinant human gamma-interferon inhibition of Chlamydia trachomatis growth. Curr. Microbiol. 16:9-13.
106. Shemer, Y., and I. Sarov. 1985. Inhibition of growth of Chlamydia trachomatis by human gamma interferon. Infect. Immun. 48:592-596.
107. Shemer-Avni, Y., D. Wallach, and I. Sarov. 1989. Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon. Infect. Immun. 57:3483-3490.
108. Shepard, M. K., and R. B. Jones. 1989. Recovery of Chlamydia trachomatis from endometrial and fallopian tube biopsies in women with infertility of tubal origin. Fertil. Steril. 52:232-238.
109. Soong, Y.-K., S.-M. Kao, C.-J. Lee, P.-S. Lee, and C. C. Pao. 1990. Endocervical chlamydial deoxyribonucleic acid in infertile women. Fertil. Steril. 54:815-818.
110. Spears, P., and J. Storz. 1979. Changes in the ultrastructure of Chlamydia psittaci produced by treatment of the host cell with DEAE-dextran and cyclohexamide. J. Ultrastruct. Res. 67:152-160.
111. Stamm, W. E. 1991. Azithromycin in the treatment of uncomplicated genital chlamydial infections. Am. J. Med. 91:19S-22S.
112. Stephens, R. S., E. A. Wagar, and U. Edman. 1988. Developmental regulation of tandem promoters for the major outer membrane protein gene of Chlamydia trachomatis. J. Bacteriol. 170:744-750.
113. Su, H., N. G. Watkins, Y.-X. Zhang, and H. D. Caldwell. 1990. Chlamydia trachomatis-host cell interactions: role of the chlamydial outer membrane protein as an adhesin. Infect. Immun. 58:1017-1025.
114. Tamura, A., A. Matsumoto, and N. Higashi. 1967. Purification and chemical composition of reticulate bodies of the meningopneumonitis organisms. J. Bacteriol. 93:2003-2008.
115. Tanami, Y., and Y. Yamada. 1973. Miniature cell formation in Chlamydia psittaci. J. Bacteriol. 114:408-412.
116. Taylor, H. R., P. A. Rapoza, S. West, S. Johnson, B. Munoz, S. Katala, and B. B. O. Mmbaga. 1989. The epidemiology of infection in trachoma. Invest. Ophthalmol. Visual Sci. 30:1823-1833.
117. Taylor, H. R., E. Young, A. B. MacDonald, J. Schachter, and R. A. Prendergast. 1987. Oral immunization against chlamydial eye infection. Invest. Ophthalmol. Vis. Sci. 28:249-258.
118. Theijls, H., J. G. Gnarpe, O. Lundkvist, G. Heimer, G. Larsson, and A. Victor. 1991. Diagnosis and prevalence of persistent chlamydia infection in infertile women: tissue culture, direct antigen detection, and serology. Fertil. Steril. 55:304-310.
119. Tribby, I. I. E., R. R. Friis, and J. W. Moulder. 1973. Effect of chloramphenicol, rifampicin, and nalidixic acid on Chlamydia psittaci growing in L cells. J. Infect. Dis. 127:155-163.
120. Wang, S. P., and J. T. Grayston. 1962. Trachoma in the Taiwan monkey, Macaco cyclopis. Ann. N. Y. Acad. Sci. 98:177-187.
121. Ward, M., R. Bailey, A. Lesley, M. Kajbaf, J. Robertson, and D. Mabey. 1990. Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia. Scand. J. Infect. Dis. Suppl. 69:137-148.
122. Ward, M. E. 1988. The chlamydial developmental cycle, p. 71-95. In A. L. Baron (ed.), Microbiology of chlamydiae. CRC Press, Inc., Boca Raton, Fla.
123. Ward, M. E., and H. Salari. 1982. Control mechanisms governing the infectivity of Chlamydia trachomatis for HeLa cells: modulation by cyclic nucleotides prostaglandins and calcium. J. Gen. Microbiol. 128:639-650.
124. Wichlan, D. G., and T. P. Hatch. 1993. Identification of an early-stage gene of Chlamydia psittaci 6BC. J. Bacteriol. 175:2936-2942.
125. Workowski, K. A., M. F. Lampe, K. G. Wong, M. B. Watts, and W. E. Stamm. 1993. Long-term eradication of Chlamydia trachomatis gential infection after antimicrobial therapy. Evidence against persistent infection. JAMA 270:2071-2075.
126. Wyrick, P. B., E. A. Brownridge, and B. E. Ivins. 1978. Interaction of Chlamydia psittaci with mouse peritoneal macrophages. Infect. Immun. 19:1061-1067.
127. Yang, Y.-S., C.-C. Kuo, and W.-J. Chen. 1983. Reactivation of Chlamydia trachomatis lung infection in mice by cortisone. Infect. Immun. 39:655-658.
128. Zeilstra-Ryalls, J., O. Fayet, and C. Georgopoulus. 1991. The universally conserved GroE (hsp60) chaperonins. Annu. Rev. Microbiol. 45:301-325.
129. Zhang, Y.-X., S. Stewart, T. Joseph, H. R. Taylor, and H. D. Caldwell. 1987. Protective monoclonal antibodies recognize epitopes located on major outer membrane protein of Chlamydia trachomatis. J. Immunol. 138:575-581.